quinapril has been researched along with Diabetes Mellitus, Type 2 in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 12 (75.00) | 29.6817 |
2010's | 2 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gregg, AM; Kloner, RA; Neutel, J; Roth, EM; Schwartz, B; Shi, H; Thakker, KM; Weinberger, MH; Weiss, R | 1 |
Bondareva, IN; Nesterov, IuI; Poltavtseva, OV; Tepliakov, AT | 2 |
Bhaheetharan, S; Ferdinand, KC; Haque, T; Khan, BV; Merchant, N; Rahman, ST; Wahi, J | 1 |
Lim, SC; Liu, JJ; Subramaniam, T; Sum, CF | 1 |
Blanco, S; Casas, I; López, D; Penin, R; Romero, R | 1 |
Abel, ED; Chuang, M; Severson, DL; Shimoni, Y | 1 |
Guven, O; Guzelsoy, D; Sipahi, I; Tekin, G; Yigit, Z | 1 |
Blanco, S; Bonet, J; Casas, I; López, D; Romero, R | 1 |
Blanco, S; Egido, J; Gómez-Guerrero, C; López, D; Romero, R; Vaquero, M | 1 |
Dominguez, H; Hansen, KW; Hawkins, M; Hermann, TS; Ihlemann, N; Kober, L; Li, W; Major-Pedersen, A; Nielsen, DB; Rask-Madsen, C; Torp-Pedersen, C | 1 |
Chua, CL; Goh, SK; Heng, BL; Koh, AF; Lim, SC; Subramaniam, T; Sum, CF | 1 |
Barrett, EJ; Clerk, LH; Lankford, MF; Lindner, JR; Vincent, MA | 1 |
Barbagallo, M; Dominguez, LJ; Garcia, D; Kattah, W; Sowers, JR | 1 |
Asplund, K; Bystedt, T; Dahlöf, B; Jern, S; Kjellström, T; Lithell, H; Ostman, J | 1 |
Shimoni, Y | 1 |
8 trial(s) available for quinapril and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 2008 |
[Combined antihypertensive treatment of patients with hypertension and type 2 diabetes mellitus].
Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hypertension; Indapamide; Lipid Metabolism; Male; Middle Aged; Quinapril; Severity of Illness Index; Tetrahydroisoquinolines; Ventricular Function, Left | 2009 |
[Combined antihypertensive therapy in patients with arterial hypertension and type 2 diabetes].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Indapamide; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines; Treatment Outcome | 2009 |
The impact of lipoic acid on endothelial function and proteinuria in quinapril-treated diabetic patients with stage I hypertension: results from the QUALITY study.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Proteinuria; Quinapril; Tetrahydroisoquinolines; Thioctic Acid | 2012 |
Elevated circulating alpha-klotho by angiotensin II receptor blocker losartan is associated with reduction of albuminuria in type 2 diabetic patients.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucuronidase; Humans; Klotho Proteins; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 2014 |
Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes.
Topics: Adiponectin; Angiotensin-Converting Enzyme Inhibitors; Base Sequence; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; DNA Primers; Endothelium, Vascular; Female; Gene Expression Regulation; Heart Rate; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Polymerase Chain Reaction; Quinapril; Tetrahydroisoquinolines | 2006 |
Angiotensin receptor antagonist vs. angiotensin-converting enzyme inhibitor in Asian subjects with type 2 diabetes and albuminuria - a randomized crossover study.
Topics: Adult; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Asian People; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Losartan; Male; Middle Aged; Quinapril; Singapore; Tetrahydroisoquinolines | 2007 |
Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
Topics: Adrenergic beta-Antagonists; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucose Tolerance Test; Hemoglobin A; Humans; Hypertension; Insulin; Isoquinolines; Lipids; Male; Metoprolol; Middle Aged; Quality of Life; Quinapril; Sweden; Tetrahydroisoquinolines | 1998 |
8 other study(ies) available for quinapril and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Desmin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; Disease Models, Animal; Drug Therapy, Combination; Linear Models; Male; Obesity; Podocytes; Proteinuria; Quinapril; Rats; Rats, Zucker; Tetrahydroisoquinolines | 2002 |
Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice.
Topics: Action Potentials; Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Separation; Cell Size; Diabetes Mellitus, Type 2; Female; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Membrane Potentials; Mice; Mice, Inbred Strains; Mice, Knockout; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Quinapril; Receptor, Insulin; Sex Characteristics; Tetrahydroisoquinolines; Ventricular Function | 2004 |
Effect of quinapril on the attenuated heart rate recovery of type 2 diabetic subjects without known coronary artery disease.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Heart Rate; Humans; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 2004 |
ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Desmin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; DNA, Complementary; Immunoenzyme Techniques; Male; Membrane Proteins; Microfilament Proteins; Obesity; Proteins; Quinapril; Rats; Rats, Zucker; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tetrahydroisoquinolines | 2005 |
Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atorvastatin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Immunoenzyme Techniques; Kidney; Kidney Glomerulus; Linear Models; Microscopy, Electron; Obesity; Pyrroles; Quinapril; Rats; Rats, Zucker; Staining and Labeling; Tetrahydroisoquinolines | 2005 |
Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Blood Volume; Capillaries; Diabetes Mellitus, Type 2; Erythrocyte Deformability; Glucose Clamp Technique; Hindlimb; Hypoglycemic Agents; Insulin; Muscle, Skeletal; Polyuria; Quinapril; Rats; Rats, Mutant Strains; Rats, Zucker; Regional Blood Flow; Tetrahydroisoquinolines; Ultrasonography, Doppler, Color | 2007 |
Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Isoquinolines; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 1995 |
Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes.
Topics: Action Potentials; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electric Conductivity; Isoquinolines; Mutation; Potassium Channels; Quinapril; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Angiotensin, Type 2; Receptors, Cell Surface; Receptors, Leptin; Saralasin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan | 2001 |